Options for first line therapy of Hodgkin lymphoma

被引：4

作者：

Longley, Jemma ^{[1
]}

Johnson, Peter W. M. ^{[1
]}

机构：

[1] Univ Southampton, Canc Res UK Ctr, Southampton, Hants, England

来源：

HEMATOLOGICAL ONCOLOGY | 2019年 / 37卷

关键词：

RESPONSE-ADAPTED THERAPY; BRENTUXIMAB VEDOTIN; EARLY-STAGE; INTERIM PET; OPEN-LABEL; TRIAL; CHEMOTHERAPY; RADIOTHERAPY; SCAN; CT;

D O I：

10.1002/hon.2597

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：82 / 86

页数：5

共 19 条

[1] Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial [J].

Andre, Marc P. E. ;

Girinsky, Theodore ;

Federico, Massimo ;

Reman, Oumedaly ;

Fortpied, Catherine ;

Gotti, Manuel ;

Casasnovas, Olivier ;

Brice, Pauline ;

van der Maazen, Richard ;

Re, Alessandro ;

Edeline, Veronique ;

Ferme, Christophe ;

van Imhoff, Gustaaf ;

Merli, Francesco ;

Bouabdallah, Reda ;

Sebban, Catherine ;

Specht, Lena ;

Stamatoullas, Aspasia ;

Delarue, Richard ;

Fiaccadori, Valeria ;

Bellei, Monica ;

Raveloarivahy, Tiana ;

Versari, Annibale ;

Hutchings, Martin ;

Meignan, Michel ;

Raemaekers, John .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (16) :1786-+

[2] PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study [J].

Barrington, Sally F. ;

Kirkwood, Amy A. ;

Franceschetto, Antonella ;

Fulham, Michael J. ;

Roberts, Thomas H. ;

Almquist, Helen ;

Brun, Eva ;

Hjorthaug, Karin ;

Viney, Zaid N. ;

Pike, Lucy C. ;

Federico, Massimo ;

Luminari, Stefano ;

Radford, John ;

Trotman, Judith ;

Fossa, Alexander ;

Berkahn, Leanne ;

Molin, Daniel ;

D'Amore, Francesco ;

Sinclair, Donald A. ;

Smith, Paul ;

O'Doherty, Michael J. ;

Stevens, Lindsey ;

Johnson, Peter W. .

BLOOD, 2016, 127 (12) :1531-1538

[3] International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers [J].

Biggi, Alberto ;

Gallamini, Andrea ;

Chauvie, Stephane ;

Hutchings, Martin ;

Kostakoglu, Lale ;

Gregianin, Michele ;

Meignan, Michel ;

Malkowski, Bogdan ;

Hofman, Michael S. ;

Barrington, Sally F. .

JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (05) :683-690

[4] PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group [J].

Borchmann, Peter ;

Goergen, Helen ;

Kobe, Carsten ;

Lohri, Andreas ;

Greil, Richard ;

Eichenauer, Dennis A. ;

Zijlstra, Josee M. ;

Markova, Jana ;

Meissner, Julia ;

Feuring-Buske, Michaela ;

Huttmann, Andreas ;

Dierlamm, Judith ;

Soekler, Martin ;

Beck, Hans-Joachim ;

Willenbacher, Wolfgang ;

Ludwig, Wolf-Dieter ;

Pabst, Thomas ;

Topp, Max S. ;

Hitz, Felicitas ;

Bentz, Martin ;

Keller, Ulrich Bernd ;

Kuhnhardt, Dagmar ;

Ostermann, Helmut ;

Schmitz, Norbert ;

Hertenstein, Bernd ;

Aulitzky, Walter ;

Maschmeyer, Georg ;

Vieler, Tom ;

Eich, Hans ;

Baues, Christian ;

Stein, Harald ;

Fuchs, Michael ;

Kuhnert, Georg ;

Diehl, Volker ;

Dietlein, Markus ;

Engert, Andreas .

LANCET, 2017, 390 (10114) :2790-2802

[5] PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study [J].

Casasnovas, Rene-Olivier ;

Bouabdallah, Reda ;

Brice, Pauline ;

Lazarovici, Julien ;

Ghesquieres, Herve ;

Stamatoullas, Aspasia ;

Dupuis, Jehan ;

Gac, Anne-Claire ;

Gastinne, Thomas ;

Joly, Bertrand ;

Bouabdallah, Krimo ;

Nicolas-Virelizier, Emmanuelle ;

Feugier, Pierre ;

Morschhauser, Franck ;

Delarue, Richard ;

Farhat, Hassan ;

Quittet, Philippe ;

Berriolo-Riedinger, Alina ;

Ternpescul, Adrian ;

Edeline, Veronique ;

Maisonneuve, Nerve ;

Fomecker, Luc-Matthieu ;

Lamy, Thiery ;

Delmer, Alain ;

Dartigues, Peggy ;

Martin, Laurent ;

Andre, Marc ;

Moonier, Nicolas ;

Traverse-Glehen, Alexandra ;

Meignan, Michel .

LANCET ONCOLOGY, 2019, 20 (02) :202-215

[6] Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma [J].

Connors, J. M. ;

Jurczak, W. ;

Straus, D. J. ;

Ansell, S. M. ;

Kim, W. S. ;

Gallamini, A. ;

Younes, A. ;

Alekseev, S. ;

Illes, A. ;

Picardi, M. ;

Lech-Maranda, E. ;

Oki, Y. ;

Feldman, T. ;

Smolewski, P. ;

Savage, K. J. ;

Bartlett, N. L. ;

Walewski, J. ;

Chen, R. ;

Ramchandren, R. ;

Zinzani, P. L. ;

Cunningham, D. ;

Rosta, A. ;

Josephson, N. C. ;

Song, E. ;

Sachs, J. ;

Liu, R. ;

Jolin, H. A. ;

Huebner, D. ;

Radford, J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (04) :331-344

[7] Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial [J].

Cottereau, Anne-Segolene ;

Versari, Annibale ;

Loft, Annika ;

Casasnovas, Olivier ;

Bellei, Monica ;

Ricci, Romain ;

Bardet, Stephane ;

Castagnoli, Antonio ;

Brice, Pauline ;

Raemaekers, John ;

Deau, Benedicte ;

Fortpied, Catherine ;

Raveloarivahy, Tiana ;

Van Zele, Emelie ;

Chartier, Loic ;

Borght, Thierry Vander ;

Federico, Massimo ;

Hutchings, Martin ;

Ricardi, Umberto ;

Andre, Marc ;

Meignan, Michel .

BLOOD, 2018, 131 (13) :1456-1463

[8] Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group [J].

Eichenauer, Dennis A. ;

Pluetschow, Annette ;

Kreissl, Stefanie ;

Soekler, Martin ;

Hellmuth, Johannes C. ;

Meissner, Julia ;

Mathas, Stephan ;

Topp, Max S. ;

Behringer, Karolin ;

Klapper, Wolfram ;

Kuhnert, Georg ;

Dietlein, Markus ;

Kobe, Carsten ;

Fuchs, Michael ;

Diehl, Volker ;

Engert, Andreas ;

Borchmann, Peter .

LANCET ONCOLOGY, 2017, 18 (12) :1680-1687

[9] Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials [J].

Eichenauer, Dennis A. ;

Becker, Ingrid ;

Monsef, Ina ;

Chadwick, Nicholas ;

de Sanctis, Vitaliana ;

Federico, Massimo ;

Fortpied, Catherine ;

Gianni, Alessandro M. ;

Henry-Amar, Michel ;

Hoskin, Peter ;

Johnson, Peter ;

Luminari, Stefano ;

Bellei, Monica ;

Pulsoni, Alessandro ;

Sydes, Matthew R. ;

Valagussa, Pinuccia ;

Viviani, Simonetta ;

Engert, Andreas ;

Franklin, Jeremy .

HAEMATOLOGICA, 2017, 102 (10) :1748-1757

[10] Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial [J].

Engert, Andreas ;

Haverkamp, Heinz ;

Kobe, Carsten ;

Markova, Jana ;

Renner, Christoph ;

Ho, Antony ;

Zijlstra, Josee ;

Kral, Zdenek ;

Fuchs, Michael ;

Hallek, Michael ;

Kanz, Lothar ;

Doehner, Hartmut ;

Doerken, Bernd ;

Engel, Nicole ;

Topp, Max ;

Klutmann, Susanne ;

Amthauer, Holger ;

Bockisch, Andreas ;

Kluge, Regine ;

Kratochwil, Clemens ;

Schober, Otmar ;

Greil, Richard ;

Andreesen, Reinhard ;

Kneba, Michael ;

Pfreundschuh, Michael ;

Stein, Harald ;

Eich, Hans Theodor ;

Mueller, Rolf-Peter ;

Dietlein, Markus ;

Borchmann, Peter ;

Diehl, Volker .

LANCET, 2012, 379 (9828) :1791-1799

← 1 2 →